These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28042240)

  • 21. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
    Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Buono JL; Carson RT; Flores NM
    Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.
    Rajindrajith S; Devanarayana NM
    J Neurogastroenterol Motil; 2012 Jul; 18(3):298-304. PubMed ID: 22837878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.
    Kaji M; Fujiwara Y; Shiba M; Kohata Y; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1151-6. PubMed ID: 20594232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.
    Remes-Troche JM; Torres-Aguilera M; Montes-Martínez V; Jiménez-García VA; Roesch-Dietlen F
    Neurogastroenterol Motil; 2015 Jun; 27(6):824-31. PubMed ID: 25817438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
    Jamali R; Biglari M
    Acta Med Iran; 2015 Nov; 53(11):717-24. PubMed ID: 26786994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
    Koloski NA; Jones M; Young M; Talley NJ
    Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.
    Simrén M; Abrahamsson H; Svedlund J; Björnsson ES
    Scand J Gastroenterol; 2001 May; 36(5):545-52. PubMed ID: 11346211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in patients with different constipation subtypes based on the Rome III criteria.
    Ruiz-López MC; Coss-Adame E
    Rev Gastroenterol Mex; 2015; 80(1):13-20. PubMed ID: 25726441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study.
    Shayesteh AA; Hajiani E; Hashemi SJ; Masjedizadeh A; Latifi SM; Shayesteh M
    J Dig Dis; 2014 Jan; 15(1):12-7. PubMed ID: 24320042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation on the health-related quality of life among 411 patients with irritable bowel syndrome].
    Wang SH; Dong L; Luo JY; Wu Q; Gong J; Zou BC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1130-2. PubMed ID: 18396673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable Bowel Syndrome and Quality of Life in Women With Fecal Incontinence.
    Markland AD; Jelovsek JE; Rahn DD; Wang L; Merrin L; Tuteja A; Richter HE; Meikle S;
    Female Pelvic Med Reconstr Surg; 2017; 23(3):179-183. PubMed ID: 27918339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.
    Kanazawa M; Miwa H; Nakagawa A; Kosako M; Akiho H; Fukudo S
    Biopsychosoc Med; 2016; 10():19. PubMed ID: 27274765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile].
    Madrid-Silva AM; Defilippi-Caffri C; Landskron-Ramos G; Olguín-Herrera F; Reyes-Ponce A; Castro-Lara A; Larraín-Corp S; Martínez-Roje N; Cortés-Espinoza J
    Rev Gastroenterol Mex; 2013; 78(4):203-10. PubMed ID: 24290320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.
    Badia X; Mearin F; Balboa A; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Pharmacoeconomics; 2002; 20(11):749-58. PubMed ID: 12201794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Related Quality of Life in Iranian Patients With Irritable Bowel Syndrome: Reliability and Validity of the Persian Version of the IBS-QOL.
    Jafari P; Asadollahi Z; Moini M; Seyed Mirzaie M
    Iran Red Crescent Med J; 2013 Aug; 15(8):723-8. PubMed ID: 24578842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
    Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease.
    Tomita T; Kato Y; Takimoto M; Yamasaki T; Kondo T; Kono T; Tozawa K; Yokoyama Y; Ikehara H; Ohda Y; Oshima T; Fukui H; Tanaka S; Shima M; Watari J; Miwa H
    J Neurogastroenterol Motil; 2016 Oct; 22(4):661-669. PubMed ID: 27193973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.
    Solem CT; Patel H; Mehta S; Mody R; Macahilig C; Gao X
    Curr Med Res Opin; 2016 May; 32(5):899-905. PubMed ID: 26836030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.